Defects in dystroglycan glycosylation are associated with a group of muscular dystrophies, termed dystroglycanopathies, that include Fukuyama congenital muscular dystrophy (FCMD). This evidence concerns the gene DAG1 and Congenital muscular dystrophy, Fukuyama type.